Article Text

PDF
NADH-cytochrome b5 reductase in a Turkish family with recessive congenital methaemoglobinaemia type I
  1. M J Percy1,
  2. D Aslan2
  1. 1Department of Haematology, Belfast City Hospital, Belfast, UK
  2. 2Section of Hematology, Department of Pediatrics, Faculty of Medicine, Gazi University, Besevler, Ankara, Turkey
  1. Dr D Aslan, Hematology Section, Department of Pediatrics, Faculty of Medicine, Gazi University, Besevler, 06500 Ankara, Turkey; drdagutf{at}superonline.com

Abstract

The development of cyanosis at birth, the so-called blue baby syndrome, alerts paediatricians to the presence of congenital heart disease. In rare cases where the arterial blood gas analysis is normal the cyanosis is a consequence of methaemoglobinaemia. There are three distinct origins of methaemoglobinaemia; the presence of a haemoglobin variant, environmental toxicity and deficiency of cytochrome b5 reductase (cb5r). Two children born to two sets of first-degree related parents were cyanotic from birth. Differential diagnosis eliminated cardiac and pulmonary abnormalities. Measurement of methaemoglobin levels confirmed recessive congenital methaemoglobinaemia (RCM) and treatment with ascorbic acid was commenced. In the absence of neurological defects, type I disease was diagnosed. Sequence analysis of CYB5R3 revealed two different missense mutations (one which is novel, Ile85Ser) in the two families. Neither of the mutations was located in the FAD or the NADH binding sites of cb5r, thus supporting a diagnosis of type I disease.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Patient consent: Obtained from the parents.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.